MAP 2019: Industry Participation

The MAP Congress is a unique and highly influential meeting driving the essential integration into daily practice of information derived from the analysis of tumour samples.

Established by Jean-Charles Soria, Fabrice André and Charles Swanton, the MAP Congress, a very dynamic, interactive forum, has become a must-attend meeting for specialists working in precision medicine in oncology.  The Congress explores all options for patients based on the genomic information obtained through the sequencing of all tumours and the tumour microenvironment. The Congress programme remains at the cutting edge of new developments including the latest findings in immunotherapy.

MAP 2019 will be the next impressive edition of the Congress which is the outcome of the enduring collaboration of Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer.

Fast Facts: MAP 2019

  • Expecting over 400 participants
  • New: 1 workshop
  • No parallel sessions
  • More than 35 key opinion leaders
  • Excellent networking opportunities

How can I participate in MAP 2019?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congress.

For sponsorship information and a prospectus please contact:

Jon Roberts
Head of Strategic Partnerships

We look forward to hearing from you!

Official Italian agency for AIFA procedure

AIFA rules are mandatory only for Italian Pharmaceutical Companies that will attend a congress abroad.

Any pharmaceutical company supporting supporting or participating in a congress, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorisation must be submitted within 60 days before the starting date of the even.

ESMO advises pharmaceutical companies to contact the Official Agency:

AIM Group International – AIM Education S.r.l.
Contact: Valentina Disabato/ Crisitina Ghidoli
Via G. Ripamonti, 129
20141 Milan – Italy
Tel.: +39 02 56601 1
Fax.: +39 02 70048585